Our use of cookies

We use necessary cookies to make our site work.

For more detailed information about the cookies we use, see our Cookie Policy.


Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Transparency Netherlands

Otsuka Pharma Scandinavia AB (OPSAB) which includes the BeNeLux region is a subsidiary of Otsuka Pharmaceutical Europe Ltd (OPEL). Otsuka Pharma Scandinavia AB (OPSAB) agrees to publically disclose certain transfers of value made directly or indirectly to healthcare professionals and healthcare organizations according to EFPIA disclosure code. This includes, but is not limited to:
  • Travel and accommodation
  • Fee for services and all consultancy
  • Any agreement related expenses or benefits (e.g. taxi, out of pocket expenses)
  • Contribution towards events and costs of meetings paid to healthcare organizations
  • Grants and donations
  • Research and development (in aggregate)
Where a HCP has not granted consent to disclosure on an individually named basis, these transfers of value are reported in aggregate. Otsuka Pharma Scandinavia AB (OPSAB) disclosure data and details on the methodology used to prepare the data can be found in the links below. Any questions relating to this information should be directed to info@otsuka.se

Date of preparation: June 2021 | Reference NOR-NPR-2100005

This website is for all those with an interest in Otsuka Pharmaceutical in the Nordics and BeNeLux.